Why Pluristem Therapeutics believe that in cell therapy “the process is the product”




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Why Pluristem Therapeutics believe that in cell therapy “the process is the product”
Released on: July 16, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics
  • Summary
  • Transcript
  • Participants
  • Company
Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics
Karine Kleinhaus, Divisional Vice President, North America, Why Pluristem Therapeutics believe that in cell therapy “the process is the product”
Pluristem Therapeutics
Pluristem
Our vision at Pluristem Therapeutics inc. is to leverage our position as the global leader in placenta-based cell science to become the world’s leader in developing and manufacturing cell therapy products. We believe our cutting edge technology can become the standard of care for treating a host of inflammatory and ischemic conditions. We are in the process of achieving this vision by building a successful, winning team to maintain our standard of excellence in the research, development and production of cell therapies.